Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Change in Account Payables (2023 - 2024)

Exozymes (EXOZ) has disclosed Change in Account Payables for 2 consecutive years, with -$4.2 million as the latest value for Q4 2024.

  • Quarterly Change in Account Payables fell 31063.83% to -$4.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$4.2 million through Dec 2024, changed N/A year-over-year, with the annual reading at -$26533.0 for FY2025, 99.37% up from the prior year.
  • Change in Account Payables for Q4 2024 was -$4.2 million at Exozymes, down from -$101492.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $1.3 million in Q1 2024, with the low at -$4.2 million in Q4 2024.